Results for “”

Entry Author Date Location
Exalys Launches With $15M to Treat Postoperative Delirium & More 07/17/20 San Diego
MeiraGTx, J&J See Phase 3 Test Ahead for Vision Loss Gene Therapy 07/17/20 New York
Two Days, Six IPOs, and $1B Raised for Biotech Research & More 07/17/20 National
Bio Roundup: Moderna Publishes, Life Science Cash, AdComm Votes & More 07/17/20 National
Adimab Spinout Adagio Raises $50M for Coronavirus Antibody R&D 07/16/20 Boston
Mallinckrodt’s Kidney Failure Drug Narrowly Wins Backing of FDA Panel 07/16/20 Europe
Moderna Publishes Early COVID-19 Vaccine Data, Preps for Phase 3 Test 07/15/20 Boston
Last Chance for Xconomy Awards Nominations – Deadline is Friday, July 17 07/15/20 Boston
Dewpoint, Merck Team Up to Tackle HIV Using Condensate Know-How 07/15/20 Boston
After Biologic COVID-19 Drug OK’d in India, Equillium Plans a US Test 07/14/20 San Diego
Roche, Blueprint Medicines Team Up Again in $775M RET Cancer Drug Pact 07/14/20 Boston
New Xconomy Podcast & Special Report Feature Boston Biophama Leaders on Digital Health 07/14/20 Boston
Amgen Doubles Down on BeiGene Collaboration, Investing $421M More 07/13/20 San Francisco
3 Biotech IPOs Together Rake In Over a Half Billion to Advance Treatments 07/13/20 National
Ovid Licenses European Rights to Lead Rare Disease Drug to Angelini Pharma 07/13/20 Boston
Bio Roundup: Blackstone’s Billions, Biogen Finishes Filing, Novavax at “Warp Speed” & More 07/10/20 National
Sanofi Pays Kymera $150M to Kick Off Protein Degrader Partnership 07/09/20 Boston
NFlection Looks to Erase NF1 Tumors With Drug That Only Goes Skin Deep 07/09/20 Philadelphia
VelosBio Tacks on $137M to Advance Its ROR1-Targeting Cancer Antibody Drugs 07/09/20 San Diego
Biogen Alzheimer’s Drug in FDA’s Court Following Completion of Filing 07/08/20 Boston
The 2020 National Xconomy Awards Expands, Goes Virtual & Reopens Nomination Period 07/08/20 National
Foghorn Therapeutics Inks Chromatin-Targeting Cancer Deal with Merck 07/08/20 Boston
Novavax Gets $1.6B in Operation Warp Speed Funding for COVID-19 Vaccine 07/07/20 National
Vor Nabs $110M to Spare Healthy Cells From Targeted Cancer Drugs 07/07/20 Boston
PacBio CEO, CFO Plan Retirements and More People on the Move 07/07/20 National
On Heels of $100M Financing, Annexon Bio Aims to Tack On More Via IPO 07/06/20 San Francisco
Bristol Myers Pays Dragonfly $55M to Bring NK Cells to Neuro Diseases 07/06/20 Boston
MEI Pharma, Helsinn Scuttle Cancer Drug Trial After Miss on Efficacy 07/02/20 San Diego
Moderna: Speed of COVID 19 Vaccine Hinges On Enrolling Right Patients 07/02/20 National
Data Quantity, Complexity Drives Use of AI in Drug Discovery and Testing 07/02/20 San Francisco
Page 2 of 1970 « previous page · next page »